Physician profile
Christopher D Caldwell
NPI 1407346802
$21,171.29
in general payments reported to CMS, 2019-2025
10 companies · $9,690 in 2025
The $9,690 reported for 2025 was more than what 87% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $955 · 2023: $3,380 · 2024: $7,147 · 2025: $9,690.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $10K · Food and Beverage: $4,465 · Travel and Lodging: $2,372.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $10,000.00 |
| Food and Beverage | $4,465.00 |
| Travel and Lodging | $2,372.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $10,335.07 | 2024-2025 | Real Intelligence, Bioinductive Implant With Arthroscopic Delivery System - Medium, Aetos Shoulder System |
| Stryker Corporation | $5,904.58 | 2024-2025 | Mako, Axsos, Triathlon |
| Convatec INC. | $132.81 | 2024 | |
| Zimmer Biomet Holdings, INC. | $119.45 | 2024 | Juggerloc |
| Skeletal Dynamics INC | $114.97 | 2025 | Geminus, Ijs, Align |
| Linvatec Corporation | $69.22 | 2024 | Biobrace 23mm |
| Orthalign INC | $62.36 | 2024 | Orthalign Plus |
| Kerecis Limited | $44.88 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Augmedics INC. | $27.50 | 2024 | Xvision |
| Merck Sharp & Dohme LLC | $26.24 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Caldwell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.